Literature DB >> 19253485

Measurement of costs.

Arthorn Riewpaiboon1.   

Abstract

Costing plays an important role in health economics, particularly economic evaluation. However, there are some controversial issues: concepts, methods and reference values. Hence, it is pivotal to standardize can be con costing methods and use these as national guidelines to produce comparable studies. This report is divided perspectives. into 3 parts: theoretical issues, international guidelines comparison, and recommendations for the Thai technology assessment guidelines. Each section is composed of three general costing steps: identification, appropriate, measuring and valuation. It is recommended to measure economic or opportunity cost mainly in societal perspective. Cost category is composed of direct medical, direct non-medical and indirect costs. The level of reliability of each kind of costing source data is provided. Valuation of resource use based on national government, standard cost menu is recommended for national policy making. The recommendations on cost measurement are appropriate for the Thai context and in the current situation.

Mesh:

Year:  2008        PMID: 19253485

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  8 in total

1.  Cost-effectiveness analysis of patient self-testing therapy of oral anticoagulation.

Authors:  Sutat Kantito; Surasak Saokaew; Sukit Yamwong; Prin Vathesatogkit; Wisuit Katekao; Piyamitr Sritara; Nathorn Chaiyakunapruk
Journal:  J Thromb Thrombolysis       Date:  2018-02       Impact factor: 2.300

2.  Economic burden of bacteremic melioidosis in eastern and northeastern, Thailand.

Authors:  Saithip Bhengsri; Jongkol Lertiendumrong; Henry C Baggett; Somsak Thamthitiwat; Wirongrong Chierakul; Kanjana Tisayaticom; Kittisak Tanwisaid; Somrak Chantra; Jaranit Kaewkungwal
Journal:  Am J Trop Med Hyg       Date:  2013-06-24       Impact factor: 2.345

3.  A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand.

Authors:  Pattara Leelahavarong; Usa Chaikledkaew; Suradej Hongeng; Vijj Kasemsup; Yoel Lubell; Yot Teerawattananon
Journal:  BMC Health Serv Res       Date:  2010-07-16       Impact factor: 2.655

4.  Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand.

Authors:  Pattara Leelahavarong; Yot Teerawattananon; Pitsaphun Werayingyong; Chutima Akaleephan; Nakorn Premsri; Chawetsan Namwat; Wiwat Peerapatanapokin; Viroj Tangcharoensathien
Journal:  BMC Public Health       Date:  2011-07-05       Impact factor: 3.295

5.  Cost of illness due to typhoid Fever in pemba, zanzibar, East Africa.

Authors:  Arthorn Riewpaiboon; Moritz Piatti; Benedikt Ley; Jacqueline Deen; Kamala Thriemer; Lorenz von Seidlein; Mohammad Salehjiddawi; Clara Jana-Lui Busch; Wolfgang H Schmied; Said Mohammed Ali
Journal:  J Health Popul Nutr       Date:  2014-09       Impact factor: 2.000

6.  Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients.

Authors:  Pochamana Phisalprapa; Siripen Supakankunti; Phunchai Charatcharoenwitthaya; Piyaporn Apisarnthanarak; Aphinya Charoensak; Chaiwat Washirasaksiri; Weerachai Srivanichakorn; Nathorn Chaiyakunapruk
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

7.  Preemptive Living-Related Kidney Transplantation Is a Cost-Saving Strategy Compared With Post-dialysis Kidney Transplantation in Thailand.

Authors:  Atthaphong Phongphithakchai; Pochamana Phisalprapa; Chayanis Kositamongkol; Nalinee Premasathian; Nuttasith Larpparisuth; Peenida Skulratanasak; Attapong Vongwiwatana
Journal:  Front Med (Lausanne)       Date:  2022-07-08

8.  An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.

Authors:  Kittiphong Thiboonboon; Pattara Leelahavarong; Duangrurdee Wattanasirichaigoon; Nithiwat Vatanavicharn; Pornswan Wasant; Vorasuk Shotelersuk; Suthipong Pangkanon; Chulaluck Kuptanon; Sumonta Chaisomchit; Yot Teerawattananon
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.